Chapter 315 - 223: The Value of a New Drug to Make the Forbes Rich List

Chapter 315: Chapter 223: The Value of a New Drug to Make the Forbes Rich List

Reading the entry’s description, Wu Ting felt a surge of excitement. ’Fengmu Tiada could actually generate such astronomical revenue!’

But on second thought, it made sense. After all, it was a curative drug for liver cancer, and the market was enormous. Otherwise, neither Jin Pharmaceutical Group nor Pfizer Pharmaceutical would value it so highly, willing to invest tens of billions into it.

During this time, Wu Ting had also learned some basic knowledge about pharmaceutical companies and new drug development:

The profits from a top-tier new drug were insane and staggering!

For example, one drug had raked in 14.2 billion dollars in just nine months, causing the Danish biopharmaceutical company Novo Nordisk’s market cap to soar to 460 billion dollars. It became the top listed company in the Southern Continent, with a valuation that dwarfed Denmark’s entire annual GDP.

That new drug was Wegovy, a semaglutide medication from Novo Nordisk. Primarily a novel drug for treating type 2 diabetes, it also had the effect of inducing weight loss!

This was why pharmaceutical groups were willing to invest billions into new drug development. After all, if they produced a single blockbuster drug, they could reap returns in the hundreds of billions.

He now had the complete theoretical foundation. All he had to do was wait for the laboratory building to be completed and for the equipment and personnel to arrive, and then Wu Ting could begin the development of Fengmu Tiada!

[Entry acquired from Lou Musaang: Common Risks of Cardiac Stents (Yellow). This encompasses the knowledge Lou Musaang researched and mastered regarding the risks following cardiac stent intervention in order to study her own condition.]

[Note: Lou Musaang’s research includes: in-stent restenosis, in-stent thrombosis, vascular dissection, aneurysm formation, acute thrombosis, cardiac perforation, sudden death, duodenal bulb ulcer, upper gastrointestinal bleeding, heart failure, acute coronary syndrome, acute renal failure, chronic superficial gastritis, cardiac rupture, pneumonia, etc. Such is the rationality and restraint of a great scientist in the face of life and death.]

Looking at this entry, Wu Ting felt a pang of sadness and sympathy. ’If a top-tier scientist like Lou Musaang hadn’t been focused on developing the Banzhe Project and had instead devoted all her energy to her own illness, perhaps she would have already made a breakthrough, right?’

Thanks to this entry, Wu Ting now had a crystal-clear understanding of the potential complications that could arise during and after cardiac stent surgery.

Wu Ting made a resolution. He had to do his best to help Lou Musaang and see if he could find a perfect surgical plan for her.

After returning to the Emergency Department, Wu Ting urged Lou Musaang to send over all the details of her medical condition.

Wu Ting read through them meticulously. With his current knowledge of cardiac surgery, it was clear he was still far from being able to help.

Without much hesitation, Wu Ting sent a message to his mentor, Shen Siyuan, expressing his desire to find time to continue his training in the Department of Cardiac Surgery.

Of course, Shen Siyuan was extremely welcoming toward Wu Ting, even pleasantly surprised.

"I thought you wouldn’t be back after getting your graduation certificate."

"This is great. Just send me a message before you come."

"Director Shao would also be very happy for you to continue observing and learning from clinical surgeries."

"By the way, are there any specific cardiac surgeries or related conditions you want to research and study...?"

Hearing that Wu Ting wanted to come back, Shen Siyuan reacted like an excited parent preparing for their child’s return from a long trip.

His messages came one after another, prattling on a bit.

Seeing the voice messages pop up one by one, Wu Ting couldn’t help but feel happy.

The next day, Wu Ting went to the Department of Cardiac Surgery at Jinggang University Affiliated First Hospital early in the morning.